Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
biotech
boston blog main
boston top stories
clinical trials
deals
drugs
national top stories
new york blog main
san diego blog main
san diego top stories
startups
achaogen
adams street partners
akcea therapeutics
alnylam pharmaceuticals
antibiotics
anylam pharmaceuticals
beijing
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
brii bio
brii biosciences
cardiomyopathy
china
drug resistance
fda
glaxosmithkline
gsk
hatteras venture partners
hepatitis b
inotersen
investing
lyzz capital
macrolide pharmaceuticals
melinta therapeutics
meropenem
michael dudley
neuropathy
What
disease
3
×
drug
3
×
medicines
year
3
×
infectious
adds
ago
akcea
alliance
alnylam
amyloidosis
approved
areas
attr
available
bacteria
battle
biopharma
biosciences
bio’s
brii
business
company
debilitating
earlier
exited
fda
fighting
genetic
hepatitis
infections
launched
launches
melinta
million
mission
new
oks
patients
pfizer
Language
Current search:
disease
×
year
×
drug
×
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
